GetTopicDetailResponse(id=546555239e8, topicName=抗凝藥物, introduction=抗凝藥物, content=null, image=null, comments=1, allHits=2037, url=https://h5.medsci.cn/topic?id=55239, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=8827, tagList=[TagDto(tagId=8827, tagName=抗凝藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2276792, encodeId=dec322e67924f, content=<a href='/topic/show?id=cf6b55e5560' target=_blank style='color:#2F92EE;'>#抗血小板藥物#</a> <a href='/topic/show?id=546555239e8' target=_blank style='color:#2F92EE;'>#抗凝藥物#</a>, objectTitle=麻醉相關(guān)抗血小板或抗凝藥物的使用要注意這些時間點, objectType=article, longId=889740, objectId=9ae7889e400f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250211/1739237818333_8538692.png, objectUrl=/article/show_article.do?id=9ae7889e400f, replyNumber=0, likeNumber=16, createdTime=2025-08-11, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9ae7889e400f, moduleTitle=麻醉相關(guān)抗血小板或抗凝藥物的使用要注意這些時間點, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9ae7889e400f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2220424, encodeId=bae62220424e0, content=<a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房顫#</a> <a href='/topic/show?id=546555239e8' target=_blank style='color:#2F92EE;'>#抗凝藥物#</a> <a href='/topic/show?id=464d11e942d4' target=_blank style='color:#2F92EE;'>#血紅蛋白變異性#</a>, objectTitle=Eur J Prev Cardiol：服用抗凝藥物的房顫患者血紅蛋白變異性與不良結(jié)局之間的關(guān)系, objectType=article, longId=839218, objectId=14e583921820, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720059469809_92910.png, objectUrl=/article/show_article.do?id=14e583921820, replyNumber=0, likeNumber=131, createdTime=2024-08-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=14e583921820, moduleTitle=Eur J Prev Cardiol：服用抗凝藥物的房顫患者血紅蛋白變異性與不良結(jié)局之間的關(guān)系, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=14e583921820)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173513, encodeId=b2ff21e3513fe, content=<a href='/topic/show?id=ab99522007b' target=_blank style='color:#2F92EE;'>#急性冠脈綜合征#</a> <a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房顫#</a> <a href='/topic/show?id=546555239e8' target=_blank style='color:#2F92EE;'>#抗凝藥物#</a>, objectTitle=要點匯總！房顫合并ACS時，抗凝藥物選擇和時機(jī), objectType=article, longId=803840, objectId=96de803840bb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=96de803840bb, replyNumber=0, likeNumber=145, createdTime=2023-12-07, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=96de803840bb, moduleTitle=要點匯總！房顫合并ACS時，抗凝藥物選擇和時機(jī), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=96de803840bb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241573, encodeId=965712415e3e3, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#靜脈血栓栓塞#</a>與<a href='/topic/show?id=546555239e8' target=_blank style='color:#2F92EE;'>#抗凝藥物#</a>, objectTitle=抗凝藥物治療靜脈血栓栓塞癥爭議與共識, objectType=guider, longId=15926, objectId=cb73f1c002328e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=cb73f1c002328e6f, replyNumber=0, likeNumber=194, createdTime=2022-08-28, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb73f1c002328e6f, moduleTitle=抗凝藥物治療靜脈血栓栓塞癥爭議與共識, moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=cb73f1c002328e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
